TumCG Cancer Research Results

TumCG, Tumor cell growth: Click to Expand ⟱
Source:
Type:
Normal cells grow and divide in a regulated manner through the cell cycle, which consists of phases (G1, S, G2, and M).
Cancer cells often bypass these regulatory mechanisms, leading to uncontrolled proliferation. This can result from mutations in genes that control the cell cycle, such as oncogenes (which promote cell division) and tumor suppressor genes (which inhibit cell division).


Scientific Papers found: Click to Expand⟱
8701- CAP,    Comparative assessment of direct and indirect cold atmospheric plasma effects, based on helium and argon, on human glioblastoma: an in vitro and in vivo study
- vitro+vivo, GBM, GBM - in-vitro, GBM, U87MG
Apoptosis↑, TumCG↓, TumCMig↓, ROS↑, TAC↓, eff↝, TumVol↓, OS↑, GFAP↓, P53↑, motorD↑,
2652- CAP,    Oxidative Stress Inducers in Cancer Therapy: Preclinical and Clinical Evidence
- Review, Var, NA
chemoPv↑, AntiCan↑, ROS↑, TumCG↓, ROS↑, MMP↑, Apoptosis↑, TumCCA↑, JNK↑, SOD↓, Catalase↓, GPx↓, other↓, SIRT1↓, NADPH↑, FOXO3↑,
5764- CAPE,    Caffeic Acid Phenethyl Ester (CAPE), Derived from a Honeybee Product Propolis, Exhibits a Diversity of Anti-tumor Effects in Preclinical Models of Human Breast Cancer
- vitro+vivo, BC, MCF7 - NA, BC, MDA-MB-231
TumCG↓, TumCCA↑, Apoptosis↑, NF-kB↓, MDR1↓, VEGF↓, angioG↓,
5763- CAPE,    Synthesis and Biological Evaluation of a Caffeic Acid Phenethyl Ester Derivatives as Anti-Hepatocellular Carcinoma Agents via Inhibition of Mitochondrial Respiration and Disruption of Cellular Metabolism
- in-vitro, HCC, NA
*antiOx↑, *neuroP↑, NF-kB↓, TumCG↓, TumMeta↓, MMPs↓, P53↑, ChemoSen↑,
5761- CAPE,    Caffeic acid phenethyl ester suppresses the proliferation of human prostate cancer cells through inhibition of AMPK and Akt signaling networks
- in-vitro, Pca, LNCaP - in-vitro, Pca, DU145 - in-vitro, Pca, PC3
TumCP↓, TumCG↓, TumCCA↑, AMPK↓, NF-kB↓, β-catenin/ZEB1↓, CREB↓, cycD1/CCND1↓, cycE/CCNE↓, CDK2↓, CDK4↓,
5760- CAPE,    Caffeic acid phenethyl ester induces growth arrest and apoptosis of colon cancer cells via the beta-catenin/T-cell factor signaling
- in-vitro, CRC, HCT116 - in-vitro, CRC, SW480
TumCG↓, TumCCA↑,
5907- CAR,    Anti-proliferative and pro-apoptotic effect of carvacrol on human hepatocellular carcinoma cell line HepG-2
- in-vitro, Liver, HepG2
TumCG↓, Apoptosis↓, Casp3↓, cl‑PARP↑, Bcl-2↓, p‑ERK↓, p‑p38↑, *Bacteria↓, *AntiAg↑, *Inflam↓, *antiOx↑, *AChE↓, AntiTum↑, MMP↓, Cyt‑c↑, Bax:Bcl2↑, Casp↑, DNAdam↑, selectivity↑,
5895- CAR,    Carvacrol as a Therapeutic Candidate in Breast Cancer: Insights into Subtype-Specific Cellular Modulation
- in-vitro, BC, MCF7 - in-vitro, BC, MDA-MB-231
TumCG↓, TumCMig↓, Apoptosis↑, Bax:Bcl2↑, ROS↓, CD44↓, CSCs↓,
5890- CAR,    Carvacrol as a Prospective Regulator of Cancer Targets/Signalling Pathways
- Review, Var, NA
selectivity↑, TumCG↓, *Inflam↓, *antiOx↑, TumCCA↑, TumCMig↓, TumCI↓, angioG↓,
5920- Cats,    Treatment with Uncaria tomentosa Promotes Apoptosis in B16-BL6 Mouse Melanoma Cells and Inhibits the Growth of B16-BL6 Tumours
- in-vivo, Melanoma, B16-BL6
eff↑, Ki-67↓, TumCP↓, Apoptosis↑, TumCG↓,
5818- CBD,    Cannabidiol's cytotoxicity in pancreatic cancer is induced via an upregulation of ceramide synthase 1 and ER stress
- in-vivo, PC, PANC1
GRP78/BiP↑, ATF4↑, CHOP/DDIT3↑, UPR↑, TumCG↓, ER Stress↑, eff↓,
5965- CEL,  Cisplatin,    Celecoxib enhances anticancer effect of cisplatin and induces anoikis in osteosarcoma via PI3K/Akt pathway
- in-vitro, OS, MG63
COX2/PTGS2↓, ChemoSen↑, MDR1↓, MRP1/ABCC1↓, E-cadherin↓, β-catenin/ZEB1↓, Apoptosis↑, TumCCA↑, TumCG↓, P-gp/ABCB1↓, PI3K↓, Akt↓,
5942- Cela,    Celastrol elicits antitumor effects by inhibiting the STAT3 pathway through ROS accumulation in non-small cell lung cancer
- vitro+vivo, NSCLC, H460 - in-vitro, NSCLC, PC9
TumCG↓, TumCP↓, TumMeta↓, ROS↑, ER Stress↑, p‑STAT3↓, Apoptosis↑, eff↓, TumCG↓, IL6↓, other↝,
5946- Cela,    The anti-cancer mechanism of Celastrol by targeting JAK2/STAT3 signaling pathway in gastric and ovarian cancer
- in-vitro, Var, NA
toxicity⇅, toxicity↓, TumCG↓, ROS↑, IL6↓, JAK2↓, STAT3↓,
5951- Cela,    Celastrol Suppresses Tumor Cell Growth through Targeting an AR-ERG-NF-κB Pathway in TMPRSS2/ERG Fusion Gene Expressing Prostate Cancer
- vitro+vivo, Pca, NA
NF-kB↓, AR↓, MCP1/CCL2↓, Akt↓, HSP90↓, TumCG↓,
6615- Cen,    Asiaticoside suppresses cell proliferation by inhibiting the NF-κB signaling pathway in colorectal cancer
- vitro+vivo, CRC, HCT116 - in-vitro, CRC, SW480 - in-vitro, CRC, LoVo
Dose↝, TumCP↓, selectivity↑, MMP↓, Apoptosis↑, TumCCA↑, NF-kB↓, CDK4↓, cycD1/CCND1↓, Casp9↑, Casp3↑, Bax:Bcl2↑, TumCG↓, ChemoSen↑, TNF-α↓, IL1β↓, P53↑, P21↑,
6653- Cen,    Antitumor Activity of Asiaticoside Against Multiple Myeloma Drug-Resistant Cancer Cells Is Mediated by Autophagy Induction, Activation of Effector Caspases, and Inhibition of Cell Migration, Invasion, and STAT-3 Signaling Pathway
- in-vitro, Melanoma, KM3/BTZ
TumCG↓, TumAuto↑, LC3‑Ⅱ/LC3‑Ⅰ↑, Casp↑, ROS↑, TumCMig↓, TumCI↓, STAT3↓,
6641- Cen,    Asiaticoside Increases Caspase-9 Activity in MCF-7 Cells and Inhibits TNF-α and IL-6 Expression in Nude Mouse Xenografts via the NF-κB Pathway
- in-vitro, BC, MCF7
Casp9↑, TNF-α↓, IL6↓, NF-kB↓, TumCG↓, Inflam↓, TumCP↓, EMT↓,
6642- Cen,    Asiaticoside inhibits breast cancer progression and tumor angiogenesis via YAP1/VEGFA signal pathway
- vitro+vivo, BC, MCF7 - in-vitro, BC, MDA-MB-231
TumCP↓, TumCI↓, angioG↓, TumCG↓, YAP/TEAD↓, VEGF↓, TumCCA↑,
6645- Cen,    Can Asiatic Acid from Centella asiatica Be a Potential Remedy in Cancer Therapy?—A Review
- Review, Var, NA
TumCD↑, TumCG↓, TumMeta↓, PI3K↓, Akt↓, mTOR↓, P70S6K↓, STAT3↓, N-cadherin↓, β-catenin/ZEB1↓, CLDN1↓, Vim↓, TumAuto↑, *BioAv↓, Casp3↑, ROS↑, MMP15↓, MMP↓, Synergy↑, *toxicity↓,
6002- CGA,    Chlorogenic Acid: A Systematic Review on the Biological Functions, Mechanistic Actions, and Therapeutic Potentials
- Review, Var, NA - Review, Diabetic, NA - Review, AD, NA - Review, Park, NA - Review, Stroke, NA
*neuroP↑, *Inflam↓, *antiOx↑, *cardioP↑, *NRF2↑, *AMPK↑, *SOD↑, *Catalase↑, *GSH↑, *GPx↑, *ROS↓, *TNF-α↓, *IL6↓, *NF-kB↓, *COX2/PTGS2↓, *glucose↓, *TRPC1↓, *Ca+2↓, *HO-1↑, *NF-kB↓, *PPARα↝, *Hif1a↓, *JNK↓, *BP↓, *AntiDiabetic↑, *hepatoP↑, *TLR4↓, *NRF2↑, *Casp↓, *neuroP↑, *Aβ↓, *LDH↓, *MDA↓, *memory↑, *AChE↓, *Stroke↓, EMT↝, N-cadherin↓, E-cadherin↑, TumCCA↑, ROS↑, p‑P53↑, HO-1↑, NRF2↑, ChemoSen↑, mtDam↑, Casp3↑, Casp9↑, PARP↑, Bax:Bcl2↑, TumCG↓, cycD1/CCND1↓, cMyc↓, CDK2↓, mitResp↓, Glycolysis↓, Hif1a↓, PCNA↓, p‑GSK‐3β↓, VEGF↓, PI3K↓, Akt↓, mTOR↓, OS↑,
6014- CGA,    Exploring the Pharmacological Potential of Chlorogenic acid as an Anti-Cancer Agent and a Call for Advance Research
- Review, Var, NA
AntiCan↑, *hepatoP↑, *Bacteria↓, *antiOx↓, *AntiDiabetic↑, Apoptosis↓, TumCG↓, angioG↓, TumCI↓, TumCMig↓, ROS↝, Inflam↝,
6030- CGA,    Chlorogenic acid induces apoptosis, inhibits metastasis and improves antitumor immunity in breast cancer via the NF‑κB signaling pathway
- vitro+vivo, BC, MDA-MB-231 - in-vitro, BC, MDA-MB-453 - in-vitro, Nor, MCF10
NF-kB↓, AntiTum↑, tumCV↓, TumCP↓, Apoptosis↑, TumCMig↓, TumCI↓, EMT↓, TumCG↓, OS↑, TumMeta↓, CD4+↑, CD8+↑, Imm↑,
7174- CHA,    Inhibition of SUV39H1 reduces tumor angiogenesis via Notch1 in oral squamous cell carcinoma
- vitro+vivo, OS, OS-RC-2
SUV39H↓, TumCG↓, NOTCH1↓, CD31/PECAM-1↓, VEGF↓, toxicity↓, Ki-67↓, angioG↓,
7178- CHA,    SUV39H1 Regulates Gastric Cancer Progression via the H3K9me3/ALDOB Axis
- in-vitro, GC, NA
tumCV↓, TumCG↓, SUV39H↓,
7180- CHA,    Chaetocin: A review of its anticancer potentials and mechanisms
- Review, Var, NA
TumCG↓, TumCP↓, Apoptosis↑, TumCCA↑, angioG↓, TumCI↓, TumCMig↓, SUV39H↓, TrxR↓, Hif1a↓, HSP90↓, ox-Trx1↑, ROS↑, PI3K↓, Akt↓, Casp3↑, Casp8↑, Casp9↑, cl‑PARP↑, Bcl-2↓, Bcl-xL↓, Mcl-1↓, XIAP↓, DR5↑, CHOP/DDIT3↑, ATF3↑, angioG↓, VEGF↑, LDHA↓, ENO1↓,
7185- CHA,    Chaetocin-induced ROS-mediated apoptosis involves ATM–YAP1 axis and JNK-dependent inhibition of glucose metabolism
- vitro+vivo, GBM, A172 - in-vitro, GBM, T98G - in-vitro, GBM, U87MG
HMTs↓, ROS↑, p‑ATM↑, YAP/TEAD↑, p‑JNK↑, TumPF↓, SUV39H↓, TrxR↓, Casp3↑, Trx1↓, H3↓, lactateProd↓, ATP↓, GlucoseCon↓, TumCG↓, Dose↝,
7173- CHA,    Natural compound chaetocin induced DNA damage and apoptosis through reactive oxygen species-dependent pathways in A549 lung cancer cells and in vitro evaluations
- in-vitro, Lung, A549
TumCG↓, TumCCA↑, ROS↑, DNAdam↑, CD47↓, *toxicity↓, MMP↓, Casp3↑, mtDam↓,
7171- CHA,    Chaetocin-mediated SUV39H1 inhibition targets stemness and oncogenic networks of diffuse midline gliomas and synergizes with ONC201
- vitro+vivo, GBM, DIPG
TumCG↓, TumCP↓, Apoptosis↓, OS↑, H3K9↓, SUV39H↓, Synergy↑, CSCs↓, SOX9↓, HGF/c-Met↓, FGF21↓, EGFR↓, PDGFR-BB↓, Wnt↓, MYCN↑, OLIG2↓, AURKB↓, HO-1↑, P21↑,
7170- CHA,    Chaetocin Abrogates the Self-Renewal of Bladder Cancer Stem Cells via the Suppression of the KMT1A–GATA3–STAT3 Circuit
- in-vivo, Bladder, NA
TumCP↓, TumCCA↑, selectivity↑, CSCs↓, SUV39H↓, GATA3↓, STAT3↓, TumCG↓, OS↑,
7164- CHA,    Chaetocin induces apoptosis in human melanoma cells through the generation of reactive oxygen species and the intrinsic mitochondrial pathway, and exerts its anti-tumor activity in vivo
- vitro+vivo, Melanoma, A375
TumCP↓, Apoptosis↑, ROS↑, eff↓, MMP↓, Cyt‑c↑, BAX↑, cl‑Casp3↑, cl‑Casp9↑, Bcl-2↓, TumCG↓, PCNA↓, tumCV↓, NRF2↑, SOD2↑, Catalase↑, NRF2↓, SOD2↓, Catalase↓, TrxR↓,
7163- CHA,    The anticancer effects of chaetocin are independent of programmed cell death and hypoxia, and are associated with inhibition of endothelial cell proliferation
- in-vitro, Lung, A549 - in-vitro, OS, U2OS - in-vitro, CRC, HCT116 - in-vitro, CRC, HeLa - in-vivo, Ovarian, SKOV3
ROS↑, Trx↓, Apoptosis↑, TumCG↓, SUV39H↓, Hif1a↓, TumCP↓, eff↓, MMP↓, TumCG↓, Dose↝, toxicity↓,
7159- CHA,    ROS-mediated inactivation of the PI3K/AKT pathway is involved in the antigastric cancer effects of thioredoxin reductase-1 inhibitor chaetocin
- vitro+vivo, GC, HGC27 - in-vitro, GC, AGS - in-vitro, GC, BGC-823 - in-vitro, GC, SGC-7901 - in-vitro, Nor, HEK293
TumCP↓, TumCCA↑, Casp↑, Apoptosis↑, TrxR1↓, ROS↑, eff↓, eff↑, PI3K↓, Akt↓, TumCG↓, cl‑PARP↑, cl‑Casp3↑, cl‑Casp9↑, cl‑Casp8↑, Bcl-2↓, Bcl-xL↓, Mcl-1↓, XIAP↓, survivin↓, TumVol↓, TumW↓, Weight∅, toxicity↓, Ki-67↓, other↝,
4489- Chit,  SeNPs,    Inhibiting Metastasis and Improving Chemosensitivity via Chitosan-Coated Selenium Nanoparticles for Brain Cancer Therapy
- in-vitro, GBM, U87MG
TumCG↓, TumCMig↓, TumCI↓, ChemoSen↑, *BBB↑, toxicity↓, eff↑, eff↑, selectivity↑, MMP2↓, MMP9↓, EPR↑,
4477- Chit,    Recent Advances in Chitosan and its Derivatives in Cancer Treatment
- Review, Var, NA
*BioAv↑, AntiTum↑, eff↑, TumCG↓, angioG↓, TumMeta↓, eff↑, *toxicity↓, other↝,
6085- CHOC,    Epicatechin-rich cocoa polyphenol inhibits Kras-activated pancreatic ductal carcinoma cell growth in vitro and in a mouse model
- in-vivo, PC, NA
selectivity↑, TumCP↓, p‑Akt↓, NF-kB↓, TumCG↓, *BioAv↑, *chemoPv↑,
6124- CHr,  EGCG,    The anticancer flavonoid chrysin induces the unfolded protein response in hepatoma cells
- in-vitro, HCC, HepG2
TumCG↓, Apoptosis↓, GRP78/BiP↑, eff↑, cl‑Casp7↑, cl‑PARP↑, Synergy↑, UPR↑, ER Stress↑, p‑eIF2α↑, XBP-1↝, Proteasome↓,
2798- CHr,    Chrysin: a histone deacetylase 8 inhibitor with anticancer activity and a suitable candidate for the standardization of Chinese propolis
- in-vitro, BC, MDA-MB-231 - in-vivo, NA, NA
HDAC↓, HDAC8↓, TumCG↓, Diff↑,
2800- CHr,    Chrysin Activates Notch1 Signaling and Suppresses Tumor Growth of Anaplastic Thyroid Carcinoma In vitro and In vivo
- in-vitro, Thyroid, NA
TumCG↓, NOTCH↑, cl‑PARP↑, Apoptosis↑,
2805- CHr,    Chrysin serves as a novel inhibitor of DGKα/FAK interaction to suppress the malignancy of esophageal squamous cell carcinoma (ESCC)
- in-vitro, ESCC, KYSE150 - in-vivo, ESCC, NA
FAK↓, GlucoseCon↓, Casp3↑, Casp7↑, p‑Akt↓, TumCG↓, Weight∅,
2793- CHr,    Chrysin Inhibits TAMs-Mediated Autophagy Activation via CDK1/ULK1 Pathway and Reverses TAMs-Mediated Growth-Promoting Effects in Non-Small Cell Lung Cancer
- in-vitro, Lung, A549 - in-vitro, Lung, H157 - in-vivo, NA, NA
TumCG↓, M2 MC↑, CDK1↓,
1033- CHr,    Chrysin inhibits hepatocellular carcinoma progression through suppressing programmed death ligand 1 expression
- vitro+vivo, HCC, NA
TumCG↓, CD4+↑, CD8+↑, PD-L1↓,
6160- Cin,    Cinnamaldehyde induces apoptosis and enhances anti-colorectal cancer activity via covalent binding to HSPD1
- vitro+vivo, CRC, HCT116
AntiTum↑, Apoptosis↑, PI3K↓, Akt↓, TumCG↓, TumCCA↑, HSP60/HSPD1↓, Ki-67↓, ChemoSen↑,
952- Cin,    Cinnamon Extract Reduces VEGF Expression Via Suppressing HIF-1α Gene Expression and Inhibits Tumor Growth in Mice
- in-vitro, BC, MDA-MB-231 - in-vitro, GBM, U251 - in-vivo, Ovarian, SKOV3
VEGF↓, Hif1a↓, p‑STAT3↓, p‑Akt↓, angioG↓, TumCG↓, TumW↓, ascitic↓,
1583- Citrate,    Extracellular citrate and metabolic adaptations of cancer cells
- Review, Var, NA
Warburg↓, OXPHOS↓, Dose∅, TumCP↓, ATP↓, ChemoSen↑, Apoptosis↑, TumCG↓, PFK1↓,
1585- Citrate,    Sodium citrate targeting Ca2+/CAMKK2 pathway exhibits anti-tumor activity through inducing apoptosis and ferroptosis in ovarian cancer
- in-vitro, Ovarian, SKOV3 - in-vitro, Ovarian, A2780S - in-vitro, Nor, HEK293
Apoptosis↑, Ferroptosis↑, Ca+2↓, CaMKII ↓, Akt↓, mTOR↓, Hif1a↓, ROS↑, ChemoSen↑, Casp3↑, Casp9↑, BAX↑, Bcl-2↓, Cyt‑c↑, GlucoseCon↓, lactateProd↓, Pyruv↓, GLUT1↓, HK2↓, PFKP↓, Glycolysis↓, Hif1a↓, p‑Akt↓, p‑mTOR↓, Iron↑, lipid-P↑, MDA↑, ROS↑, H2O2↑, mtDam↑, GSH↓, GPx↓, GPx4↓, NADPH/NADP+↓, eff↓, FTH1↓, LC3‑Ⅱ/LC3‑Ⅰ↑, NCOA4↑, eff↓, TumCG↓,
1577- Citrate,    Citric acid promotes SPARC release in pancreatic cancer cells and inhibits the progression of pancreatic tumors in mice on a high-fat diet
- in-vivo, PC, NA - in-vitro, PC, PANC1 - in-vitro, PC, PATU-8988 - in-vitro, PC, MIA PaCa-2
Apoptosis↑, TumCP↓, TumCG↑, SPARC↑, Glycolysis↓, OCR↓, pol-M1↑, pol-M2 MC↓, Weight∅, ATP↓, ECAR↓, mitResp↓, i-ATP↑, p65↓, i-Ca+2↑, eff↓,
1574- Citrate,    Citrate Suppresses Tumor Growth in Multiple Models through Inhibition of Glycolysis, the Tricarboxylic Acid Cycle and the IGF-1R Pathway
- in-vitro, Lung, A549 - in-vitro, Melanoma, WM983B - in-vivo, NA, NA
TumCG↓, ChemoSen↑, T-Cell↑, p‑IGF-1R↓, p‑Akt↓, PTEN↑, p‑eIF2α↑, OCR↓, ROS↓, ECAR∅, IL1↑, TNF-α↑, IL10↑, IGF-1R↓, eIF2α↑, PTEN↑, TCA↓, Glycolysis↓, selectivity↑, *toxicity∅, Dose∅,
6146- Citrate,    Citric acid promotes SPARC release in pancreatic cancer cells and inhibits the progression of pancreatic tumors in mice on a high‐fat diet
- in-vitro, PC, NA
Apoptosis↑, TumCP↓, TumCG↓, SPARC↑, Glycolysis↓, OCR↓, ATP↓, NF-kB↓, Ca+2↑,
4761- CoQ10,    Elevated levels of mitochondrial CoQ10 induce ROS-mediated apoptosis in pancreatic cancer
- in-vitro, PC, NA - in-vivo, PC, NA
*ETC↝, ROS↑, *antiOx↑, ROS↑, OCR↓, MMP↓, TumCD↑, TumCG↓, other↝,

Showing Research Papers: 201 to 250 of 989
Prev Page 5 of 20 Next

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 989

Pathway results for Effect on Cancer / Diseased Cells:


NA, unassigned(tgid=0) ⓘ

NA↓, 1,   NA↑, 1,   NA↝, 1,  

Redox & Oxidative Stress(tgid=1) ⓘ

antiOx↓, 2,   antiOx↑, 6,   antiOx⇅, 1,   ARE↑, 1,   Catalase↓, 5,   Catalase↑, 4,   ENOX2↓, 2,   Fenton↑, 7,   GPx↓, 3,   GPx↑, 4,   GPx4↓, 19,   GSH↓, 52,   GSH↑, 3,   i-GSH↓, 1,   GSH/GSSG↓, 5,   GSR↓, 1,   GSR↑, 1,   GSSG↓, 1,   GSTs↓, 1,   H2O2↓, 4,   H2O2↑, 10,   i-H2O2↑, 1,   mt-H2O2↑, 1,   HO-1↓, 8,   HO-1↑, 11,   hyperG↓, 1,   Iron↓, 2,   Iron↑, 11,   Iron∅, 1,   i-Iron↑, 3,   c-Iron↑, 1,   Keap1↑, 1,   lipid-P↓, 4,   lipid-P↑, 20,   MDA↓, 2,   MDA↑, 11,   NADH↓, 1,   NADHdeh?, 1,   NADPH/NADP+↓, 2,   NOX2↑, 1,   NQO1?, 1,   NQO1↓, 1,   NQO1↑, 3,   Nrf1↓, 1,   Nrf1↑, 1,   NRF2↓, 15,   NRF2↑, 16,   NRF2↝, 1,   ox-PrxI↑, 1,   RNS↑, 2,   ROMO1↑, 1,   ROS?, 3,   ROS↓, 21,   ROS↑, 274,   ROS⇅, 3,   ROS↝, 2,   ROS∅, 1,   i-ROS↑, 1,   mt-ROS↑, 9,   SOD↓, 5,   SOD↑, 4,   SOD1↓, 2,   SOD1↑, 1,   SOD2↓, 4,   SOD2↑, 6,   TAC↓, 3,   TBARS↓, 1,   Thiols↓, 1,   i-Thiols↓, 1,   TKT↝, 1,   TOS↑, 1,   Trx↓, 2,   Trx↑, 1,   Trx1↓, 2,   ox-Trx1↑, 1,   TrxR↓, 7,   TrxR↑, 1,   TrxR1↓, 3,   xCT/SLC7A11↓, 12,  

Metal & Cofactor Biology(tgid=2) ⓘ

Ferritin↓, 3,   Ferritin↑, 1,   FPN↝, 1,   FTH1↓, 3,   IronCh↑, 1,   LIP↑, 1,   NCOA4↑, 2,   Tf↑, 1,   TfR1/CD71↓, 1,   TfR1/CD71↝, 1,  

Mitochondria & Bioenergetics(tgid=3) ⓘ

CDC2↓, 3,   p‑CDC2↓, 1,   CDC25↓, 10,   CDC25↑, 2,   CDC25↝, 1,   compI↓, 2,   compIII↓, 1,   EGF↓, 2,   ETC↓, 8,   HSP60/HSPD1↓, 4,   HSP60/HSPD1↑, 1,   Insulin↓, 3,   mitResp↓, 7,   mitResp↑, 2,   mtDam?, 1,   mtDam↓, 2,   mtDam↑, 26,   OCR↓, 10,   OCR↑, 5,   OXPHOS↓, 5,   OXPHOS↑, 10,   mt-OXPHOS↓, 1,   PDH↓, 2,   PDH↑, 6,   p‑PDH↓, 1,   PGC-1α↓, 1,   PGC-1α↑, 1,   PHB↑, 1,   PINK1↑, 2,   SIRT3↑, 2,  

Core Metabolism/Glycolysis(tgid=4) ⓘ

12LOX↓, 3,   5LO↓, 3,   ACC↓, 1,   ACC-α↓, 2,   ACC1↓, 1,   Acetyl-CoA↓, 1,   ACLY↓, 5,   ACSL4↑, 3,   Alanine↓, 1,   ALAT↓, 5,   ALAT∅, 1,   AMP↓, 1,   AMPK↓, 2,   AMPK↑, 23,   AMPK↝, 1,   p‑AMPK↑, 4,   ARG↓, 1,   ATGL/PNPLA2↓, 1,   ATP↓, 38,   ATP↑, 3,   i-ATP↑, 1,   Buty↑, 1,   CAIX/CA9↓, 1,   CAIX/CA9↑, 1,   cAMP↓, 1,   cAMP⇅, 1,   i-citrate↑, 1,   CRM↑, 3,   DHODH↓, 1,   ECAR↓, 7,   ECAR∅, 1,   ENO1↓, 3,   FABP4↑, 1,   FABP5/E-FABP↓, 1,   FASN↓, 7,   FDG↓, 1,   FFA/NEFA↓, 1,   G6PD↓, 1,   GALNT10↓, 1,   GAPDH↓, 4,   GLS↓, 1,   glucoNG↓, 1,   glucose↓, 2,   GlucoseCon↓, 26,   GlucoseCon↑, 3,   GlutMet↓, 1,   Glycine↓, 1,   Glycolysis↓, 57,   Glycolysis↑, 2,   GPI↓, 1,   GSK‐3β↓, 4,   GSK‐3β↑, 4,   p‑GSK‐3β↓, 2,   p‑GSK‐3β↑, 1,   HK2↓, 25,   HK2∅, 1,   HMG-CoA↓, 7,   HSL/LIPE↓, 1,   p‑HSL/LIPE↑, 1,   IDH1↑, 1,   KeyT↑, 1,   lactateProd↓, 29,   lactateProd↑, 2,   LDHA↓, 19,   LDHA∅, 1,   LDL↓, 2,   lipidLev↓, 1,   lipoGen↓, 2,   MATs↓, 1,   MCT4↓, 2,   MethCyc↓, 1,   NAD↓, 2,   NADPH↓, 1,   NADPH↑, 1,   NPC1L1↓, 1,   PA↑, 2,   PDK1 / PDPK1↓, 8,   PDKs↓, 4,   PFK↓, 4,   PFK1↓, 5,   PFKP↓, 3,   PKM1↑, 1,   PKM2↓, 21,   p‑PKM2↓, 1,   polyA↓, 1,   PPP↓, 2,   Pyruv↓, 3,   Pyruv↑, 1,   R5P↝, 1,   SCFAs↑, 1,   SIRT1↓, 8,   SIRT1↑, 3,   SREBF2↓, 1,   SREBP1/SREBF1↓, 4,   TCA↓, 2,   TCA↑, 2,   TPI↓, 1,   TS↓, 1,   Warburg↓, 14,   Warburg↑, 1,  

Cell Death(tgid=5) ⓘ

AIF↑, 11,   APAF1↑, 1,   Apoptosis↓, 12,   Apoptosis↑, 381,   Apoptosis∅, 2,   mt-Apoptosis↑, 1,   ASC↑, 1,   ASK1↑, 1,   BAD↓, 3,   BAD↑, 3,   Bak↑, 3,   BAX↓, 2,   BAX↑, 113,   BAX↝, 1,   Bax:Bcl2↑, 32,   Bcl-2?, 1,   Bcl-2↓, 150,   Bcl-2↑, 1,   Bcl-xL↓, 36,   Bcl-xL↑, 3,   BID↓, 1,   BID↑, 5,   cl‑BID↑, 1,   BIM↑, 6,   BNIP3↑, 1,   BNIP3↝, 1,   Casp↑, 38,   Casp↝, 1,   Casp1↓, 2,   Casp1↑, 1,   cl‑Casp1↑, 1,   Casp12↑, 1,   Casp3?, 1,   Casp3↓, 3,   Casp3↑, 134,   cl‑Casp3↓, 1,   cl‑Casp3↑, 52,   proCasp3↓, 1,   CASP4↑, 2,   Casp6↓, 1,   Casp6↑, 1,   Casp7↑, 17,   cl‑Casp7↑, 4,   Casp8↓, 1,   Casp8↑, 32,   cl‑Casp8↑, 11,   Casp9↓, 1,   Casp9↑, 65,   p‑Casp9↑, 1,   cl‑Casp9↓, 1,   cl‑Casp9↑, 12,   cFLIP↓, 2,   Cupro↑, 1,   Cyt‑c↓, 1,   Cyt‑c↑, 77,   Cyt‑c↝, 1,   cl‑Cyt‑c↑, 1,   Diablo↑, 1,   DR5↑, 11,   Endon↑, 1,   FADD↑, 3,   Fap1↓, 1,   Fas↓, 4,   Fas↑, 7,   FasL↓, 2,   FasL↑, 5,   Ferroptosis↓, 1,   Ferroptosis↑, 31,   GSDMC↑, 1,   GSDMD↑, 1,   cl‑GSDMD↑, 1,   cl‑GSDME↑, 3,   GSDME-N↑, 1,   HEY1↓, 2,   IAP1↓, 7,   IAP2/BIRC3↓, 3,   ICD↑, 2,   iNOS↓, 4,   Mcl-1↓, 17,   MDM2↓, 6,   MDM2↑, 1,   MLKL↑, 2,   p‑MLKL↓, 1,   MOMP↑, 2,   Necroptosis↑, 4,   necrosis↑, 6,   NOXA↑, 3,   p38↓, 5,   p38↑, 13,   p‑p38↓, 3,   p‑p38↑, 3,   PUMA↑, 3,   Pyro↑, 11,   RIP3↑, 2,   p‑RIP3↑, 2,   survivin↓, 48,   survivin↑, 1,   TNFR 1↑, 1,   TRAIL↑, 2,   TRAILR↑, 1,   TumCD↓, 2,   TumCD↑, 26,   TumCD∅, 1,   TUNEL↑, 1,   XIAP↓, 17,   YAP/TEAD↓, 10,   YAP/TEAD↑, 2,  

Kinase & Signal Transduction(tgid=6) ⓘ

ABL1↓, 1,   Akt↓, 117,   Akt↑, 6,   p‑Akt↓, 41,   p‑Akt↑, 1,   AKT1↓, 4,   BCAP↓, 1,   BRAF↓, 2,   BRAF↑, 1,   CaMKII ?, 1,   CaMKII ↓, 3,   CIP2A↓, 1,   cMET↓, 5,   CREB↓, 2,   p‑CREB↓, 1,   cSrc↓, 1,   DDIT4?, 1,   DYRK1B↓, 1,   EGFR↓, 29,   EGFR↝, 1,   p‑EGFR↓, 1,   ERK↓, 24,   ERK↑, 6,   ERK↝, 1,   p‑ERK↓, 15,   p‑ERK↑, 3,   e-ERK↑, 1,   FLT3↓, 1,   FOXD3↑, 1,   HER2/EBBR2↓, 10,   p‑HER2/EBBR2↓, 1,   HGF/c-Met↓, 3,   Hippo↑, 1,   IGF-1R↓, 4,   p‑IGF-1R↓, 1,   IGFR↓, 3,   p‑IGFR↓, 1,   IKKα↓, 8,   IKKα↑, 1,   p‑IKKα↓, 2,   IκB↑, 1,   p‑IκB↓, 2,   JAK↓, 4,   JAK1?, 1,   JAK1↓, 3,   p‑JAK1↓, 2,   JAK2↓, 13,   p‑JAK2↓, 4,   JNK↓, 3,   JNK↑, 15,   JNK↝, 1,   p‑JNK↓, 2,   p‑JNK↑, 3,   cl‑JNK↑, 1,   LIFR/CD118↓, 1,   MAPK↓, 18,   MAPK↑, 11,   p‑MAPK↑, 2,   MARK4↓, 1,   MEK↓, 3,   MEK↑, 1,   p‑MEK↓, 1,   mTOR↓, 64,   mTOR↑, 7,   p‑mTOR↓, 8,   p‑mTOR↑, 1,   mTORC2↓, 2,   mTORC2↑, 1,   NIK↓, 1,   OR13G1?, 1,   p‑p70S6↓, 2,   P70S6K↓, 4,   P70S6K↑, 1,   p‑P70S6K↓, 2,   p‑P70S6K↑, 1,   PDE3B↓, 1,   PDGFR-BB↓, 1,   PDGFRA↓, 3,   PDGFRB↓, 1,   PI3K↓, 79,   PI3K↑, 2,   PI3K↝, 1,   p‑PI3K↓, 6,   PI3K/Akt↓, 4,   PI3K/Akt↑, 1,   p‑PI3k/Akt/mTOR↓, 1,   PKA↓, 2,   p‑PKA↓, 1,   PKCδ↓, 5,   p‑PKCδ↓, 2,   PPP2R1A↑, 1,   PTEN↓, 3,   PTEN↑, 15,   PTK2B / PYK2↓, 1,   Raf↓, 3,   RAS↓, 5,   Rictor↓, 1,   RIP1↑, 1,   RSK2/RPS6KA3/p90RSK2↓, 1,   Sp1/3/4↓, 12,   Sp1/3/4↑, 1,   Src↓, 3,   STAT↓, 4,   STAT3↓, 64,   STAT3↑, 1,   STAT3↝, 1,   p‑STAT3↓, 16,   p‑STAT3↑, 2,   STAT4↑, 1,   STAT5↓, 2,   p‑STAT5↓, 1,   SYK↑, 1,   TSC2↑, 1,  

Transcription & Epigenetics(tgid=7) ⓘ

ATF1↓, 1,   ATF2↓, 1,   ATF3↑, 2,   ATF4↑, 10,   BRD4↓, 1,   CBP↓, 1,   ChrMod↑, 2,   cJun↓, 3,   cJun↑, 2,   cMyc↓, 37,   cMyc↑, 1,   DNMT1↓, 6,   DNMT3A↓, 1,   DNMT3B↓, 2,   DNMTs↓, 5,   EZH2↓, 3,   FOXM1↓, 2,   FOXO1↓, 2,   FOXO1↑, 3,   FOXO3↓, 1,   FOXO3↑, 3,   FOXO3↝, 1,   p‑FOXO3↓, 1,   GATA3↓, 1,   H19↑, 1,   H3↓, 2,   H3↑, 1,   ac‑H3↑, 2,   H3K4↓, 1,   H3K9↓, 1,   H4↑, 1,   ac‑H4↑, 1,   HATs↓, 2,   HATs↑, 1,   HDAC↓, 27,   HDAC↑, 1,   HDAC1↓, 2,   HDAC2↓, 4,   HDAC3↓, 2,   HDAC4↓, 1,   HDAC6↓, 1,   HDAC8↓, 2,   HMTs↓, 1,   KLF2↓, 1,   KLF5↓, 1,   miR-106b↓, 1,   miR-122-5p↑, 1,   miR-133a-3p↑, 1,   miR-139-5p↑, 1,   miR-140↑, 1,   miR-141↑, 1,   miR-155↓, 1,   miR-199↓, 1,   miR-200b↑, 1,   miR-200c↑, 1,   miR-203↑, 1,   miR-205↑, 2,   miR-21↓, 3,   miR-22↑, 1,   miR-27a-3p↓, 2,   miR-29b↓, 1,   miR-29b↑, 1,   miR-30a-5p↑, 1,   miR-330-5p↑, 1,   miR-34a↓, 1,   miR-34a↑, 4,   miR-375↑, 1,   miR-486↑, 1,   miR-542↓, 1,   Myc↓, 5,   MYCN↑, 1,   OCT4↓, 15,   OLIG2↓, 1,   other?, 1,   other↓, 4,   other↑, 8,   other↝, 27,   PhotoS↑, 1,   SD↑, 1,   SOX2↓, 9,   SOX9↓, 2,   SUV39H↓, 7,   SUZ12↓, 1,   TCF-4↓, 1,   tumCV?, 1,   tumCV↓, 81,   tumCV∅, 2,  

Protein Folding & ER Stress(tgid=8) ⓘ

ATF6↑, 2,   CHOP/DDIT3↑, 18,   CHOP/DDIT3↝, 1,   eIF2α↑, 5,   p‑eIF2α↑, 6,   ER Stress↑, 39,   ERStress↑, 1,   GRP78/BiP↓, 1,   GRP78/BiP↑, 12,   GRP94↑, 1,   HSP27↓, 2,   HSP70/HSPA5↓, 1,   HSP70/HSPA5↑, 2,   HSP72↑, 1,   HSP90↓, 7,   HTRA↓, 2,   IRE1↑, 4,   NPL4↓, 1,   PDI↑, 1,   PERK↓, 1,   PERK↑, 8,   p‑PERK↑, 1,   Proteasome↓, 3,   UPR↓, 1,   UPR↑, 11,   XBP-1↑, 1,   XBP-1↝, 1,  

Autophagy & Lysosomes(tgid=9) ⓘ

ATG13↑, 1,   ATG3↓, 1,   ATG3↑, 1,   ATG5↑, 6,   ATG7↑, 1,   autoF↓, 1,   autolysosome↑, 1,   Beclin-1/ATG6↓, 2,   Beclin-1/ATG6↑, 13,   CTSB↓, 1,   CTSD↓, 1,   CTSL↑, 1,   LC3‑Ⅱ/LC3‑Ⅰ↑, 5,   LC3B↑, 3,   LC3B-II↑, 3,   LC3II↓, 1,   LC3II↑, 11,   LC3s↓, 1,   LC3s↑, 2,   lysosome↓, 1,   MitoP↑, 1,   p62↓, 7,   p62↑, 6,   PARK2↑, 1,   SESN2↑, 1,   TumAuto↓, 3,   TumAuto↑, 57,   TumAuto↝, 1,  

DNA Damage & Repair(tgid=10) ⓘ

ATM↑, 1,   p‑ATM↑, 1,   ATR↑, 1,   DFF45↓, 1,   DNAdam↑, 64,   DNAdam⇅, 1,   mt-DNAdam↑, 1,   DNArepair↓, 1,   DNArepair↑, 1,   hTERT/TERT↓, 3,   MGMT↓, 1,   NHEJ↓, 1,   p16↑, 1,   P53?, 1,   P53↓, 3,   P53↑, 65,   P53↝, 3,   P53∅, 1,   p‑P53↑, 6,   PARP↓, 2,   PARP↑, 14,   p‑PARP↑, 2,   cl‑PARP↑, 63,   PARP1↓, 2,   PARP1↑, 2,   cl‑PARP1↑, 2,   PCNA↓, 23,   SAPK↑, 1,   Telomerase↓, 5,   TOP1↓, 2,   TOP2↓, 4,   TOP2↑, 1,   TP53↑, 1,   TRF2↓, 1,   γH2AX↑, 9,   γH2AX↝, 1,   p‑γH2AX↑, 2,  

Cell Cycle & Senescence(tgid=11) ⓘ

ANAPC2↑, 1,   AURKB↓, 1,   AURKB↑, 1,   BRD4↓, 1,   CC(CDKs/cyclins)↑, 1,   CDK1↓, 15,   CDK1↑, 1,   CDK1↝, 1,   CDK1/2/5/9↓, 1,   CDK2↓, 17,   CDK2↑, 2,   p‑CDK2↓, 1,   CDK4↓, 27,   CDK4↑, 3,   CDK4/6↓, 1,   CDK6↓, 7,   CDK6↑, 3,   CDK8↓, 1,   cellSen↑, 1,   CHK1↓, 2,   CHK1↑, 1,   CHK1↝, 1,   Chk2↑, 2,   p‑Chk2↑, 1,   Cyc↓, 3,   cycA1/CCNA1↓, 6,   cycA1/CCNA1↑, 1,   CycB/CCNB1↓, 21,   CycB/CCNB1↝, 1,   cycD1/CCND1↓, 74,   cycD1/CCND1↑, 1,   cycE/CCNE↓, 9,   cycE/CCNE↑, 1,   cycE1↓, 2,   cycF↑, 1,   E2Fs↓, 4,   GADD45A↑, 2,   Ki-67↓, 57,   Ki-67↑, 1,   mitA↑, 2,   p19↑, 1,   P21↓, 3,   P21↑, 58,   p27/CDKN1B↓, 2,   p27/CDKN1B↑, 19,   PLK1↓, 1,   pRB↓, 1,   pRB↑, 1,   RB1↓, 1,   RB1↑, 1,   p‑RB1↓, 2,   cl‑RB1↓, 1,   Securin↓, 2,   TubPol↓, 2,   TumCCA↓, 7,   TumCCA↑, 256,   β-Tubulin↓, 1,  

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

4E-BP1↓, 1,   4E-BP1↑, 1,   p‑4E-BP1↓, 1,   ALDH↓, 7,   ALDH1A1↓, 2,   ALDH1A3↓, 1,   Axin2↑, 1,   BMI1↓, 4,   BMP7/OP1↓, 1,   CD133↓, 12,   CD133↑, 1,   CD24↓, 4,   CD34↓, 2,   CEBPB?, 1,   cFos↓, 4,   CSCs↓, 49,   CSCs↑, 2,   CSCsMark↓, 1,   Diff↑, 13,   EP4/PTGER4↑, 1,   FGF↓, 1,   FOSL1↑, 1,   Gli↓, 1,   Gli1↓, 20,   Gli1∅, 1,   GTPBP4↓, 1,   HH?, 1,   HH↓, 20,   HMGCR↓, 2,   HMGCR↑, 1,   Id1↓, 1,   IGF-1↓, 10,   IGF-1↑, 1,   IGFBP3↓, 1,   IGFBP3↑, 2,   Ki-67↓, 57,   Ki-67↑, 1,   Let-7↑, 1,   LRP6↓, 2,   mTORC1↓, 6,   Nanog↓, 12,   Nestin↓, 1,   NOTCH↓, 8,   NOTCH↑, 1,   NOTCH1↓, 8,   NOTCH1↝, 1,   NOTCH2↑, 2,   NOTCH3↓, 3,   p300↓, 1,   Piezo1↑, 2,   PTCH1↓, 8,   PTCH2↓, 1,   Shh↓, 7,   Smo↓, 8,   Smo∅, 1,   STAT1↓, 1,   Sufu↓, 1,   Sufu↑, 1,   TAZ↓, 2,   TumCG?, 11,   TumCG↓, 962,   TumCG↑, 18,   TumCG⇅, 2,   TumCG↝, 3,   TumCG∅, 6,   TumCP↓, 214,   TumCP↑, 6,   Wnt↓, 27,   Wnt/(β-catenin)↓, 4,  

Migration(tgid=13) ⓘ

AGRN↓, 1,   AKR1C2↓, 1,   AntiAg↑, 2,   AP-1↓, 4,   AP-1↝, 1,   ARG1/2↑, 1,   CA↓, 2,   Ca+2↓, 2,   Ca+2↑, 25,   Ca+2↝, 2,   i-Ca+2↑, 4,   Cal1↑, 1,   Cav1↓, 1,   Cav1↑, 1,   CCAT1↓, 1,   CD11b↓, 1,   i-Chl↑, 1,   COL11A1↓, 1,   CTNNB1↓, 1,   E-cadherin↓, 2,   E-cadherin↑, 43,   E-cadherin↝, 1,   EMT?, 1,   EMT↓, 64,   EMT↝, 1,   EpCAM↓, 1,   FAK↓, 11,   FAK↑, 1,   Fibronectin↓, 2,   Galectin-9↓, 1,   GIT1↓, 1,   GLI2↓, 5,   ITGA5↓, 2,   ITGB1↓, 3,   LEF1↓, 2,   MALAT1↓, 2,   MET↑, 1,   MMP1↓, 3,   MMP13↓, 2,   MMP15↓, 1,   MMP2↓, 54,   proMMP2↓, 1,   MMP3↓, 2,   MMP7↓, 6,   MMP9↓, 71,   MMPs↓, 8,   MTA1↓, 1,   MUC1↓, 1,   MUC1-C↓, 1,   N-cadherin↓, 27,   N-cadherin↝, 1,   Na+↑, 2,   NCAM↓, 1,   NFAT↑, 1,   p‑p44↓, 1,   PAK1↓, 1,   PCBP1↓, 1,   PDGF↓, 1,   Rac1↓, 1,   RECK↑, 1,   Rho↓, 2,   ROCK1↓, 1,   Slug↓, 11,   p‑SMAD2↓, 1,   SMAD3↓, 1,   Snail↓, 18,   SPARC↑, 2,   talin↓, 1,   TET1↓, 1,   TGF-β↓, 7,   TGF-β1↓, 2,   TIMP1↑, 4,   TIMP2↑, 4,   TRIB3↑, 2,   TSP-1↑, 2,   TumCA↓, 3,   TumCI?, 2,   TumCI↓, 112,   TumCI↑, 2,   TumCMig?, 2,   TumCMig↓, 123,   TumCMig↑, 2,   TumMeta?, 1,   TumMeta↓, 91,   TumMeta↑, 5,   TumPF↓, 4,   Twist↓, 8,   TXNIP↓, 1,   TXNIP↑, 2,   uPA↓, 7,   uPAR↓, 2,   Vim↓, 28,   Zeb1↓, 8,   Zeb1↑, 1,   ZEB2↓, 1,   α-SMA↓, 2,   α-tubulin↓, 4,   ac‑α-tubulin↑, 1,   β-catenin/ZEB1↓, 38,  

Angiogenesis & Vasculature(tgid=14) ⓘ

angioG↓, 89,   angioG↑, 2,   CD31/PECAM-1↓, 8,   CD31/PECAM-1↑, 1,   ECM/TCF↓, 3,   EGR1↑, 1,   EGR4↓, 1,   Endoglin↑, 1,   eNOS↓, 1,   HIF-1↓, 3,   Hif1a↓, 50,   Hif1a↑, 1,   Hif1a↝, 1,   NO↓, 5,   NO↑, 2,   VCAM-1↓, 3,   VEGF↓, 84,   VEGF↑, 2,   VEGFR1↓, 2,   VEGFR2/KDR/Flk1↓, 13,   VM↓, 1,  

Barriers & Transport(tgid=15) ⓘ

AQPs↓, 1,   BBB↑, 7,   CellMemb↓, 1,   CellMemb↑, 4,   CLDN1↓, 1,   CLDN7↑, 1,   EPR↑, 9,   GLUT1↓, 11,   GLUT1↑, 1,   GLUT2↓, 1,   GLUT3↓, 1,   GLUT3↑, 1,   GLUT4↓, 2,   IBI↑, 1,   K+↑, 1,   memfluid↓, 1,   MMP?, 1,   MMP↓, 134,   MMP↑, 5,   MPT↑, 4,   Na+↑, 2,   NHE1↓, 1,   OCLN↑, 1,   TRPM7↑, 2,   TRPV1↓, 1,   TRPV1↑, 1,   TRPV1↝, 1,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

ALC∅, 1,   CCL20↑, 1,   CD155↓, 1,   CD25+↓, 2,   CD4+↓, 3,   CD4+↑, 10,   CD44↓, 18,   CD44↝, 1,   CD47↓, 1,   CD8+↑, 12,   cDC2↓, 2,   p‑cDC2↓, 2,   cGAS–STING↑, 1,   CLP↑, 1,   COX1?, 1,   COX2/PTGS2?, 1,   COX2/PTGS2↓, 31,   COX2/PTGS2↑, 2,   CXCc↓, 1,   CXCL1↓, 1,   CXCL12↓, 1,   CXCL9↓, 1,   CXCR4↓, 9,   DCells↑, 3,   DR4↑, 2,   DR6↑, 1,   FOXP3↓, 1,   FoxP3+↓, 2,   Gal-3↓, 2,   GM-CSF↓, 3,   HLA-I/II↑, 1,   HMGB1↓, 4,   HMGB1↑, 1,   ICAM-1↓, 8,   IFN-γ↓, 2,   IFN-γ↑, 3,   IL1↓, 5,   IL1↑, 2,   IL10↓, 2,   IL10↑, 2,   IL12↓, 1,   IL12↑, 4,   IL18↑, 2,   IL1β↓, 9,   IL1β↑, 1,   IL2↓, 3,   IL2↑, 3,   IL4↑, 1,   IL6?, 1,   IL6↓, 22,   IL6↑, 2,   IL8↓, 7,   Imm↑, 22,   Imm↝, 1,   Inflam↓, 27,   Inflam↝, 1,   LPS↓, 1,   pol-M1↑, 1,   M2 MC↓, 1,   M2 MC↑, 1,   pol-M2 MC↓, 2,   Macrophages↑, 1,   MCP1/CCL2↓, 2,   MDSCs↓, 1,   mPGES-1↓, 1,   MyD88↓, 1,   NAF1↓, 1,   NF-kB↓, 111,   NF-kB↑, 5,   NF-kB⇅, 1,   NF-kB↝, 1,   p‑NF-kB↓, 3,   NK cell↑, 8,   NLRP3↓, 2,   NLRP3↑, 3,   p50↓, 1,   p65↓, 7,   p‑p65↓, 4,   PD-1↓, 2,   PD-L1↓, 19,   PD-L2↓, 1,   PGE2↓, 9,   PSA↓, 12,   T-Cell↑, 8,   TCF↓, 3,   Th1 response↑, 1,   TILs↑, 2,   TIM-3↓, 2,   TIRAP↓, 1,   TLR4↓, 3,   TLR4↝, 1,   TNF-α?, 1,   TNF-α↓, 13,   TNF-α↑, 4,   TNFRSF25/DR3/APO3/LARD/TRAMP/WSL1↑, 1,   Treg lymp↓, 2,  

Cellular Microenvironment(tgid=17) ⓘ

ADAM17↓, 1,   GFAP↓, 1,   pH↓, 2,   pH↑, 3,   pH↝, 1,   e-pH↑, 10,   i-pH↓, 1,   i-pH↑, 1,   TAMS↓, 1,  

Synaptic & Neurotransmission(tgid=18) ⓘ

SYN1↑, 1,  

Protein Aggregation(tgid=19) ⓘ

BACE/β-secretase↓, 1,   XO↓, 1,  

Hormonal & Nuclear Receptors(tgid=20) ⓘ

ACTH↓, 1,   AR↓, 18,   COMT↑, 1,   CYP11A1↓, 1,   CYP19↓, 1,   DHT↓, 1,   ER-α36↓, 1,   ER(estro)↓, 2,   ERα/ESR1↓, 2,   ERβ/ESR2↑, 2,   FGF21↓, 1,   GR↓, 1,   HSD3B↓, 1,   PPARα↑, 1,   PPARα↝, 1,   PPARγ↑, 2,   RANKL↓, 2,   SRD5A1↑, 1,   StAR↓, 1,   SXR↓, 1,   testos↓, 1,  

Drug Metabolism & Resistance(tgid=21) ⓘ

ABC↓, 1,   ABCG2↓, 1,   BioAv↓, 27,   BioAv↑, 24,   BioAv↝, 11,   ChemoSen?, 1,   ChemoSen↓, 4,   ChemoSen↑, 155,   ChemoSen∅, 2,   CompStab↓, 2,   CompStab↑, 1,   CompStab↝, 2,   CYP1A1↓, 1,   CYP1A1↑, 1,   CYP3A4↓, 1,   DDS↑, 1,   Dose?, 4,   Dose↓, 6,   Dose↑, 7,   Dose⇅, 2,   Dose↝, 104,   Dose∅, 13,   DrugR↓, 1,   eff?, 1,   eff↓, 84,   eff↑, 107,   eff↝, 16,   eff∅, 2,   Half-Life↓, 6,   Half-Life↑, 2,   Half-Life↝, 8,   Half-Life∅, 2,   MDR1↓, 6,   MRP1/ABCC1↓, 3,   P-gp/ABCB1↓, 11,   P-gp/ABCB1↝, 1,   P-gp/ABCB1∅, 1,   P450↓, 2,   P450↑, 1,   RadioS?, 1,   RadioS↑, 44,   RadioS↝, 1,   selectivity?, 1,   selectivity↓, 3,   selectivity↑, 128,   selectivity↝, 1,   selectivity∅, 1,   Synergy↑, 100,   TET2↑, 1,  

Clinical Biomarkers(tgid=22) ⓘ

AFP↓, 1,   ALAT↓, 5,   ALAT∅, 1,   AR↓, 18,   ascitic↓, 2,   AST↓, 4,   AST∅, 1,   BG↓, 4,   BMD↑, 3,   BP↓, 1,   BRAF↓, 2,   BRAF↑, 1,   EGFR↓, 29,   EGFR↝, 1,   p‑EGFR↓, 1,   ERα/ESR1↓, 2,   EZH2↓, 3,   Ferritin↓, 3,   Ferritin↑, 1,   FOXM1↓, 2,   HER2/EBBR2↓, 10,   p‑HER2/EBBR2↓, 1,   hTERT/TERT↓, 3,   IL6?, 1,   IL6↓, 22,   IL6↑, 2,   KeyT↑, 1,   LDH↓, 8,   LDH↑, 2,   p‑LDH↓, 1,   Myc↓, 5,   PD-L1↓, 19,   PSA↓, 12,   PSADT↑, 1,   SUZ12↓, 1,   TG/TAG↓, 1,   TP53↑, 1,   TRIB3↑, 2,   Tumccf↓, 3,  

Functional Outcomes(tgid=23) ⓘ

AntiAge↑, 2,   AntiArt↑, 1,   AntiCan↓, 1,   AntiCan↑, 62,   AntiCan?, 1,   antiCG↓, 1,   antiNeop↑, 4,   antiNeop∅, 1,   AntiTum↑, 40,   Appetite↑, 1,   BowelM↑, 1,   breath↑, 1,   cachexia↓, 3,   cardioP↑, 7,   CardioT↓, 1,   chemoP↓, 1,   chemoP↑, 24,   chemoPv↑, 19,   ChemoSideEff↓, 7,   cognitive↑, 1,   fatigue∅, 1,   FTO↑, 1,   hepatoP↑, 5,   hepatoP∅, 1,   kidSt↓, 1,   motorD↑, 1,   neuroP↑, 5,   Obesity↓, 1,   OS↑, 62,   OS⇅, 1,   Pain↓, 5,   PDE4↓, 1,   QoL↑, 7,   QoL∅, 2,   radioP↑, 7,   Remission↑, 5,   Risk↓, 28,   Risk↑, 1,   Sleep↑, 1,   Strength↑, 4,   toxicity↓, 49,   toxicity↑, 4,   toxicity⇅, 1,   toxicity↝, 14,   toxicity∅, 9,   TumNum↓, 3,   TumVol↓, 38,   TumW↓, 22,   Weight↑, 4,   Weight∅, 10,  

Infection & Microbiome(tgid=24) ⓘ

AntiBio↑, 1,   AntiP↑, 2,   Bacteria↓, 3,   GutMicro↑, 13,   Sepsis↓, 1,  

Ingredients & Constituents(tgid=25) ⓘ

Ingr?, 2,   Ingr↝, 8,  
Total Targets: 1168

Pathway results for Effect on Normal Cells:


Redox & Oxidative Stress(tgid=1) ⓘ

antiOx↓, 7,   antiOx↑, 50,   ARE↑, 1,   Catalase↑, 12,   DPPH↓, 1,   GPx↑, 12,   GPx1↑, 1,   GSH↓, 2,   GSH↑, 19,   GSR↑, 3,   GSTs↑, 6,   H2O2↓, 2,   HO-1↑, 11,   lipid-P↓, 14,   MDA↓, 11,   NQO1↑, 1,   NRF2↑, 16,   ROS↓, 52,   ROS↑, 4,   ROS∅, 2,   mt-ROS↓, 1,   SOD↑, 18,   SOD1↑, 1,   SOD2↓, 1,   TBARS↓, 1,   Trx↓, 1,   Trx↑, 1,  

Metal & Cofactor Biology(tgid=2) ⓘ

IronCh↑, 1,  

Mitochondria & Bioenergetics(tgid=3) ⓘ

EGF↓, 1,   ETC↝, 1,   mitResp↑, 1,   OCR↓, 1,   OXPHOS↑, 1,   SIRT3↑, 1,  

Core Metabolism/Glycolysis(tgid=4) ⓘ

5LO↓, 5,   adiP↑, 1,   ALAT?, 1,   ALAT↓, 6,   AMPK↓, 1,   AMPK↑, 4,   ATP↓, 1,   ATP↑, 1,   ECAR∅, 1,   glucose↓, 3,   GlucoseCon↑, 3,   GSK‐3β↓, 1,   GSK‐3β↑, 1,   LDL↓, 6,   lipidLev↓, 1,   NAD↓, 1,   NADPH↓, 1,   PONs↓, 1,   SIRT1↑, 6,  

Cell Death(tgid=5) ⓘ

Apoptosis↓, 5,   Apoptosis↑, 1,   ASC↓, 1,   BAX↓, 3,   BAX↑, 1,   Bax:Bcl2↓, 1,   Bcl-2↓, 1,   Bcl-2↑, 1,   Casp↓, 1,   Casp1↓, 2,   Casp3↓, 4,   Casp3↑, 1,   cl‑Casp8↑, 1,   Casp9↓, 2,   Cyt‑c↓, 2,   Cyt‑c↑, 1,   Ferroptosis↑, 1,   iNOS↓, 7,   iNOS↑, 1,   necrosis↓, 1,   survivin↓, 1,  

Kinase & Signal Transduction(tgid=6) ⓘ

Akt↓, 2,   p‑Akt↑, 1,   Akt2↓, 1,   CREB↑, 1,   p‑CREB↑, 1,   ERK↑, 2,   IKKα↓, 1,   JNK↓, 1,   JNK↑, 1,   MAPK↓, 2,   MAPK↑, 1,   mTOR↓, 2,   mTOR↑, 1,   PTEN↓, 1,   STAT↓, 1,  

Transcription & Epigenetics(tgid=7) ⓘ

AntiThr↑, 3,   ATF4↓, 1,   cJun↓, 1,   cMyc↓, 1,   FOXO3↑, 1,   other?, 1,   other↓, 2,   other↑, 6,   other↝, 2,   tumCV↓, 1,  

Protein Folding & ER Stress(tgid=8) ⓘ

CHOP/DDIT3↓, 1,   HSP27↑, 1,   HSP70/HSPA5↑, 1,   HSPs↓, 1,  

Autophagy & Lysosomes(tgid=9) ⓘ

Beclin-1/ATG6↓, 1,   LC3II↓, 1,  

DNA Damage & Repair(tgid=10) ⓘ

DNAdam↓, 4,   P53↓, 2,   PCNA↓, 1,  

Cell Cycle & Senescence(tgid=11) ⓘ

CDK2↓, 1,   CDK4↓, 1,   cycD1/CCND1↓, 2,   cycE/CCNE↓, 1,   GADD34↓, 1,   P21↓, 2,   RB1↓, 1,  

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

Diff↑, 1,   IGF-1↑, 1,   neuroG↑, 1,   TumCG↓, 5,   TumCG↑, 1,   TumCG∅, 1,   TumCP↓, 1,   tyrosinase↓, 1,  

Migration(tgid=13) ⓘ

AntiAg↑, 4,   AP-1↓, 2,   BACH1↓, 1,   Ca+2↓, 3,   Ca+2↑, 2,   Ca+2∅, 1,   i-Ca+2↓, 1,   EMT↓, 1,   MLC2/MYL9↝, 1,   MMP9↓, 1,   MMPs↓, 1,   Snail↑, 1,   TGF-β↓, 2,   TIMP1↓, 1,   TumCI↓, 1,   TumMeta↓, 1,   Twist↑, 1,   Vim↑, 1,  

Angiogenesis & Vasculature(tgid=14) ⓘ

angioG↓, 1,   angioG↑, 1,   HIF-1↓, 1,   Hif1a↓, 1,   Hif1a↑, 1,   HIF2a↑, 1,   NO↓, 5,   VCAM-1↓, 2,   VEGF↓, 1,  

Barriers & Transport(tgid=15) ⓘ

BBB↓, 1,   BBB↑, 3,   BBB↝, 2,   CellMemb↑, 1,   GLUT2↑, 1,   GLUT3↑, 1,   GLUT4↑, 2,   MMP↓, 1,   MMP↑, 2,   OCLN↝, 1,   TJ↑, 1,   TRPC1↓, 1,   TRPV1↑, 1,   ZO-1↑, 1,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

CD19↑, 1,   CD4+↑, 2,   CD8+↑, 1,   COX1↓, 3,   COX2/PTGS2↓, 13,   HMGB1↓, 1,   ICAM-1↓, 1,   IFN-γ↓, 2,   IFN-γ↑, 1,   IL1↓, 1,   IL10↓, 1,   IL10↑, 2,   IL12↓, 1,   IL17↓, 2,   IL1β↓, 7,   IL2↑, 1,   IL6↓, 14,   IL8↓, 2,   Imm↓, 1,   Imm↑, 5,   Inflam↓, 57,   Inflam↑, 1,   IRF3↓, 1,   MyD88↓, 1,   Neut↑, 1,   NF-kB↓, 15,   NK cell↑, 2,   NLRP3↓, 2,   NLRP3↑, 1,   PGE2↓, 5,   TLR2↓, 2,   TLR4↓, 5,   TNF-α↓, 13,   TNF-α↑, 1,   TRIF↓, 1,   VitD↑, 1,  

Cellular Microenvironment(tgid=17) ⓘ

pH↝, 1,  

Synaptic & Neurotransmission(tgid=18) ⓘ

5HT↓, 1,   5HT↑, 1,   Ach↑, 1,   AChE↓, 8,   AChE↑, 1,   AChE↝, 1,   BDNF↓, 1,   BDNF↑, 6,   ChAT↑, 1,   GABA↑, 1,   MAOA↓, 1,   NGF↑, 1,   TrkB↑, 1,   β-Endo↑, 1,  

Protein Aggregation(tgid=19) ⓘ

Aβ↓, 6,   XO↓, 1,  

Hormonal & Nuclear Receptors(tgid=20) ⓘ

PPARα↝, 1,   PPARγ↓, 1,   PPARγ↑, 3,  

Drug Metabolism & Resistance(tgid=21) ⓘ

BioAv?, 1,   BioAv↓, 11,   BioAv↑, 24,   BioAv↝, 7,   BioEnh↑, 3,   CompStab↑, 1,   CYP3A2↓, 1,   Dose?, 2,   Dose⇅, 1,   Dose↝, 4,   eff↑, 4,   Half-Life↓, 3,   Half-Life↝, 3,   Half-Life∅, 1,   P450↓, 3,   selectivity↑, 3,   Synergy↑, 3,  

Clinical Biomarkers(tgid=22) ⓘ

ALAT?, 1,   ALAT↓, 6,   ALP↓, 1,   AST↓, 7,   BMD↑, 2,   BP↓, 3,   colonLen↑, 1,   CRP↓, 4,   hs-CRP↓, 1,   IL6↓, 14,   LDH↓, 2,   LDH↑, 1,   TC↓, 1,   VitD↑, 1,  

Functional Outcomes(tgid=23) ⓘ

Analgesic↑, 1,   AntiAge↑, 3,   antiAll↑, 3,   AntiArt↑, 4,   AntiCan↑, 6,   AntiDiabetic↑, 8,   AntiTum↑, 2,   cardioP↑, 27,   chemoP↑, 5,   chemoPv↑, 6,   cognitive↑, 12,   DCR∅, 1,   hepatoP↑, 20,   memory↑, 13,   motorD↑, 1,   neuroP↑, 36,   ORR∅, 1,   OS↑, 3,   Pain↓, 2,   PDE4↓, 1,   PFS∅, 1,   QoL↑, 1,   radioP↑, 2,   RenoP↓, 1,   RenoP↑, 4,   Stroke↓, 2,   toxicity↓, 40,   toxicity↑, 3,   toxicity↝, 7,   toxicity∅, 12,   Weight↓, 1,   Wound Healing↑, 1,  

Infection & Microbiome(tgid=24) ⓘ

AntiBio↑, 1,   AntiFungal↑, 2,   AntiP↑, 2,   AntiViral↑, 5,   Bacteria↓, 11,   GutMicro↑, 6,   Sepsis↓, 1,  

Ingredients & Constituents(tgid=25) ⓘ

Ingr↑, 2,   Ingr↝, 5,  
Total Targets: 292

Scientific Paper Hit Count for: TumCG, Tumor cell growth
29 Curcumin
29 Magnetic Fields
19 Phenethyl isothiocyanate
17 Quercetin
17 Sulforaphane (mainly Broccoli)
17 Magnetic Field Rotating
14 Berberine
14 EGCG (Epigallocatechin Gallate)
13 Silver-NanoParticles
13 Chemotherapy
13 Shikonin
12 Vitamin C (Ascorbic Acid)
12 Magnolol
12 Bicarbonate(Sodium)
11 Alpha-Lipoic-Acid
11 Melatonin
11 Baicalein
11 Garcinol
11 phytic acid, Inositol hexakisphosphate
10 Benzyl isothiocyanate
10 Capsaicin
10 Apigenin (mainly Parsley)
10 chaetocin
10 Fisetin
9 Cucurbitacin
9 Silymarin (Milk Thistle) silibinin
9 Resveratrol
9 Dichloroacetate
9 Deguelin
9 Formononetin
9 Phenylbutyrate
8 Astragalus
8 Radiotherapy/Radiation
8 Artemisinin
8 salinomycin
8 diet FMD Fasting Mimicking Diet
8 Emodin
8 Gambogic Acid
8 Ginkgetin
8 Honokiol
8 Ivermectin
8 Matrine
8 Magnesium
8 Pterostilbene
8 Urolithin
7 Allyl isothiocyanate
7 Cisplatin
7 Allicin (mainly Garlic)
7 HydroxyCitric Acid
7 Ashwagandha(Withaferin A)
7 immunotherapy
7 Boron
7 Boswellia (frankincense)
7 Crocetin
7 Isoliquiritigenin
7 Lycopene
7 mebendazole
7 methylseleninic acid
6 Metformin
6 Betulinic acid
6 Chrysin
6 Coenzyme Q10
6 Gemcitabine (Gemzar)
6 diet Methionine-Restricted Diet
6 Sulfasalazine
6 Indole-3-carbinol
6 Inulin Prebiotic
6 itraconazole
6 Juglone
6 Rosmarinic acid
6 α-Santalol/Sandalwood oil
5 chitosan
5 doxorubicin
5 Paclitaxel/Taxol
5 Berbamine
5 Beta-Caryophyllene
5 Centella asiatica / Gotu kola → asiaticoside
5 Citric Acid
5 Diindolylmethane
5 Dandelion Root
5 Eugenol
5 Gallic acid
5 Graviola
5 isoquercitrin
5 Linalool
5 Luteolin
4 3-bromopyruvate
4 Fenbendazole
4 Astaxanthin
4 Atorvastatin
4 Dipyridamole
4 Brucea javanica
4 Butyrate
4 Caffeic Acid Phenethyl Ester (CAPE)
4 Cynaropicrin
4 Docosahexaenoic Acid
4 Disulfiram
4 Evodiamine
4 Flaxseed/Linseed
4 Genistein (soy isoflavone)
4 Hydrogen Gas
4 Hyperoside
4 Isobavachalcone
4 Inositol
4 Nimbolide
4 Marjoram (Origanum majorana)
4 Terpinen-4-ol / Tea Tree Oil
4 Piperine
4 Piperlongumine
4 Selenite (Sodium)
4 Thymoquinone
4 Vitamin K2
4 VitK3,menadione
4 Zyflamend
3 Caffeic acid
3 Diclofenac
3 Baicalin
3 Bufalin/Huachansu
3 brusatol
3 Bruteridin(bergamot juice)
3 NTP, Non-Thermal Plasma,Cold Atmospheric Plasma
3 Carvacrol
3 Celastrol
3 Chlorogenic acid
3 Selenium NanoParticles
3 Copper and Cu NanoParticles
3 Photodynamic Therapy
3 tamoxifen
3 Ellagic acid
3 eicosapentaenoic acid
3 Fucoidan
3 Geraniol
3 Ginger/6-Shogaol/Gingerol
3 Glabrescione B
3 Gossypol/AT-101
3 HydroxyTyrosol
3 MCT, metronomic chemo
3 Isorhamnetin
3 Licochalcone A
3 Licorice
3 Lemongrass Extract/Citral
3 SDG/lignans
3 Modified Citrus Pectin
3 Mangiferin
3 Niclosamide (Niclocide)
3 Patchouli Oil (Pogostemon cablin)
3 Propyl gallate
3 Plumbagin
3 Aflavin-3,3′-digallate
2 2-DeoxyGlucose
2 Auranofin
2 5-fluorouracil
2 Phyllanthus emblica/Emblica officinalis/Amla / Indian Gooseberry
2 Andrographis
2 Anethole/trans-Anethole
2 Fennel Oil/Foeniculum vulgare
2 Ascorbyl Palmitate
2 Biochanin A
2 Bifidobacterium
2 Bromelain
2 α-Bisabolol / Chamomile oil
2 Carnosic acid
2 Cinnamon
2 Cynara scolymus/Globe Artichoke/Artichoke Extract
2 Polyphenols
2 Chlorella (Chlorella vulgaris)
2 Cyclopamine
2 Oxygen, Hyperbaric
2 diet Short Term Fasting
2 D-limonene
2 Ginkgo biloba-EGb 761
2 ferumoxytol
2 Galloflavin
2 Ginkgo biloba
2 Ginkgolide B
2 Grapeseed extract
2 Hydroxycinnamic-acid
2 iodine
2 Isothiocyanates
2 Isovitexin
2 Kaempferol
2 Lutein
2 Methylene blue
2 Moringin
2 Methylsulfonylmethane
2 Mushroom Chaga, Inonotus obliquus
2 Mushroom Lion’s Mane, Hericium erinaceus
2 Mushroom Maitake
2 Oroxylin-A
2 Oleuropein
2 Orlistat
2 Phycocyanin
2 Psoralidin
2 Hyperthermia
2 EMF
2 Oxaliplatin
2 Spermidine
2 Ursolic acid
2 Vitexin
2 Whole Body Vibration
1 1,8-Cineole
1 Açaí, Euterpe oleracea
1 Anzaroot, Astragalus fasciculifolius Bioss
1 octreotide
1 Acetyl-l-carnitine
1 DTS(dibenzyl trisulphide) from Anamu
1 Angelica archangelica / Garden Angelica
1 Anti-oxidants
1 5-Aminolevulinic acid
1 Aloe anthraquinones
1 beta-glucans
1 temozolomide
1 Bacopa monnieri
1 Black Rice, Oryza sativa
1 Bullatacin
1 Caffeine
1 urea
1 Cat’s Claw
1 Cannabidiol
1 Celecoxib
1 Chocolate
1 Cranberry
1 Calorie Restriction Mimetics
1 Carvone
1 Bicalutamide
1 CUSP9
1 Dichloroacetophenone(2,2-)
1 Dasatinib/Phyrago
1 Bortezomib
1 Date Fruit Extract
1 diet Ketogenic
1 diet Plant based
1 Ormeloxifene (Centchroman)
1 Aspirin
1 Zinc
1 Echinacea
1 PXD, phenoxodiol
1 Sorafenib (brand name Nexavar)
1 Electrical Pulses
1 erastin
1 Eurycomanone
1 Flaxseed Oil
1 Shilajit/Fulvic Acid
1 Ginkgolic acids
1 Hibiscus sabdariffa
1 capecitabine
1 L-Theanine
1 Lactobacillus
1 probiotics
1 Laetrile B17 Amygdalin
1 Lapachol
1 Lasiodin
1 Lactoferrin/Talactoferrin
1 MBE, Maqui berry
1 MCT oil
1 Methyl Jasmonate
1 vp16, etoposide
1 Methylglyoxal
1 magnetic nanoparticles
1 Morin
1 Mistletoe/Viscum album Extracts
1 Naringin
1 Noscapine
1 Aromatherapy
1 Purple Corn / Purple Maize
1 Parthenolide
1 Broccoli
1 raloxifen
1 Salvia officinalis
1 Vorinostat
1 Selenium
1 irinotecan
1 Salvia miltiorrhiza
1 Saikosaponin B1 and D
1 Sutherlandioside D
1 cetuximab
1 Taurine
1 Tomatine
1 triptolide
1 Tumor Treating Fields
1 Turmerones
1 Usnic acid
1 Vitamin B1/Thiamine
1 Vitamin B5,Pantothenic Acid
1 Transarterial Chemoembolization
1 Walnut
1 γ-Tocotrienol
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:%  Target#:323  State#:%  Dir#:%
wNotes=0 sortOrder:rid,rpid

 

Home Page